We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
-0.43%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$18.6B
AUM Growth
-$1.59B
Cap. Flow
-$881M
Cap. Flow %
-4.75%
Top 10 Hldgs %
25.83%
Holding
430
New
84
Increased
94
Reduced
203
Closed
27

Top Buys

Rank Stock Value
1
AFRM icon
Affirm
AFRM
+$241M
2
TWLO icon
Twilio
TWLO
+$60M
3
XYZ
Block Inc
XYZ
+$50.5M
4
BBIO icon
BridgeBio Pharma
BBIO
+$50M
5
SOFI icon
SoFi Technologies
SOFI
+$45.9M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$398M
2
ROKU icon
Roku
ROKU
+$137M
3
MTCH icon
Match Group
MTCH
+$117M
4
GS icon
Goldman Sachs
GS
+$107M
5
ENPH icon
Enphase Energy
ENPH
+$96M

Sector Composition

Rank Sector Weight
1 Technology 26.52%
2 Healthcare 23.41%
3 Consumer Discretionary 18.52%
4 Communication Services 12.03%
5 Miscellaneous 6.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMT icon
151
American Tower
AMT
$82.9B
$18.3M 0.1%
76,423
-145
-0.2% -$32.3K
BHVN
152
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$18M 0.1%
263,420
+162,113
+160% +$13.1M
DIS icon
153
Walt Disney
DIS
$188B
$17.6M 0.09%
95,250
+2,795
+3% +$515K
RSVAU
154
DELISTED
Rodgers Silicon Valley Acquisition Corp. Unit
RSVAU
$16.9M 0.09%
1,137,153
-1,929,474
-63% -$33.4M
DEN
155
DELISTED
Denbury Inc.
DEN
$16.6M 0.09%
+347,479
New +$12.7M
ENVX icon
156
Enovix
ENVX
$663M
$16.6M 0.09%
+1,423,115
New +$18.7M
BMBL icon
157
Bumble
BMBL
$395M
$16.2M 0.09%
+259,198
New +$17.5M
FTHM icon
158
Fathom Holdings
FTHM
$20M
$15.7M 0.08%
429,416
-44,645
-9% -$1.83M
MPWR icon
159
Monolithic Power Systems
MPWR
$56.2B
$15.5M 0.08%
43,990
-355
-0.8% -$129K
MTCH icon
160
Match Group
MTCH
$9.91B
$15.5M 0.08%
113,093
-775,944
-87% -$117M
OPFI icon
161
OppFi
OPFI
$663M
$15M 0.08%
+1,469,569
New +$15.4M
SBUX icon
162
Starbucks
SBUX
$113B
$14.7M 0.08%
134,432
+120,570
+870% +$12.7M
SGTX
163
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$14.6M 0.08%
50,324
-617
-1% -$245K
VOR icon
164
Vor Biopharma
VOR
$1.37B
$14.3M 0.08%
+16,576
New +$14M
SI
165
DELISTED
Silvergate Capital Corporation
SI
$13.4M 0.07%
+94,138
New +$11.2M
BECN
166
DELISTED
Beacon Roofing Supply, Inc.
BECN
$13M 0.07%
248,360
+5,141
+2% +$240K
WSC icon
167
WillScot Mobile Mini Holdings
WSC
$3.38B
$12.6M 0.07%
453,121
-1,059
-0.2% -$27.8K
BWIN
168
Baldwin Insurance Group
BWIN
$2.87B
$12.3M 0.07%
450,268
-470
-0.1% -$12.8K
PDD icon
169
Pinduoduo
PDD
$113B
$12M 0.06%
89,292
-97,162
-52% -$16.4M
SENS icon
170
Senseonics Holdings Inc
SENS
$461M
$11.7M 0.06%
222,012
-501,993
-69% -$28.5M
GTM
171
ZoomInfo Technologies
GTM
$1.22B
$11.7M 0.06%
239,662
-26,083
-10% -$1.31M
SIVB
172
DELISTED
SVB Financial Group
SIVB
$11.5M 0.06%
23,361
-471
-2% -$232K
CTOS icon
173
Custom Truck One Source
CTOS
$2.07B
$11.5M 0.06%
1,233,237
+516,699
+72% +$4.21M
BEAM icon
174
Beam Therapeutics
BEAM
$2.49B
$11.5M 0.06%
143,900
+14,189
+11% +$1.35M
GDX icon
175
VanEck Gold Miners ETF
GDX
$28.3B
$11.5M 0.06%
352,917
-12,165
-3% -$414K

Similar funds

Gilder Gagnon Howe & Co's Q1 2021 Portfolio in Review

As of Q1 2021, Gilder Gagnon Howe & Co held 430 positions worth $18.6B, down 7.9% from $20.1B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $881M in Q1 2021, closing 27 positions and reducing 203 holdings. Its most notable exit was Eidos Therapeutics, Inc. Common Stock, an estimated $43.8M position sold in full.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Affirm worth $175M.

  • Gilder Gagnon Howe & Co's largest Q1 2021 buy was Affirm: 2,479,834 shares worth $175M.
  • Gilder Gagnon Howe & Co added most to Twilio in Q1 2021, an estimated $60M increase.
  • Gilder Gagnon Howe & Co's biggest Q1 2021 reduction was Tesla, cutting an estimated $398M.
  • Gilder Gagnon Howe & Co fully exited Eidos Therapeutics, Inc. Common Stock in Q1 2021, selling an estimated $43.8M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 26% of its $18.6B portfolio in Q1 2021.
  • Gilder Gagnon Howe & Co opened 84 new positions and closed 27 in Q1 2021.
  • Gilder Gagnon Howe & Co's portfolio value fell 7.9% quarter-over-quarter to $18.6B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2021, filed 17 May 2021.